Moderna Inc

Business news, market intelligence, and global industry analysis.

The Latest

Representative image of a legal and workplace rights dispute in India after the National Human Rights Commission notices and the Supreme Court filing intensified focus on the Nashik workplace harassment and coercion case involving Tata Consultancy Services.

TCS Nashik case: NHRC directs three-year POSH audit across all TCS branches

Nexstar Media Group (NASDAQ: NXST) faces post-closing merger shock as judge halts TEGNA integration

Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling

Why Lockheed Martin’s $101.6 m Army award matters more than its size suggests for LMT stock

Moderna Inc. resolves global mRNA patent battle in $2.25 billion deal, removing major legal risk

What Moderna Inc.’s settlement with Arbutus Biopharma Corporation means for the future of mRNA medicines

Moderna stock surged after hours after settling a $2.25B patent dispute with Arbutus Biopharma and Genevant Sciences. Discover what it means for mRNA vaccines.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

March 4, 2026